.png)
Your health is personal.
So why isn't your treatment?
Your medicine dose is likely based upon your body weight or size. This century-old approach poorly considers the large variability in how individuals distribute, break-down and clear drugs from the body.
The impact is poor long-term quality of life associated with side-effects of critical medicine, costly management of adverse events and high-risk drug development.
Vesynta places evidence-based clinical insight in the hands of the user, ensuring tailored, safe and effective dosing for every patient.
The patients we help
Patients groups especially disadvantaged with the ‘one size fits all’ dosing approach.
Paediatrics (under 16 years of age)
Patients on dose intense regimens
Elderly
Patients with rare genetic disorders
Small and large physiques
Patients on narrow therapeutic index drugs
The value of bedside
personalised care
Earlier medicines optimisation Personalised dose modifications to safer and more effective levels,
Improving patient quality of life
Reducing adverse events and sub-optimal treatment
Ensure data quality and security
Reliable response prediction and continuous refinement
Champion care standards
Focus on under-represented patients such as children
Empower patients and physicians
Full treatment ownership is provided via point-of-care access, ease of use and automation
Reduces healthare inequalities
Bedside access to high quality personal care reagardless of geographic or economic status